N/A N=64 Improving the Health of South African Women With Traumatic Stress in HIV Care (C0147)
HIV · Trauma Exposure
Primary: PTSD Symptoms — 25.79; 23.04; 28.61; 22.50 score on a scale — p=0.08
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 3 N=1,046 Cancer Venous Thromboembolism (VTE)
Venous Thromboembolism (VTE) · Deep Vein Thrombosis (DVT) · Pulmonary Embolism (PE)
Primary: Number of Participants With Adjudicated Recurrent Venous Thromboembolism (VTE) or Major Bleeding Event — 67; 71 Participants — p=0.0056
Phase 1 N=82 Effects of RLIC on Motor Learning in Middle-aged and Older Adults
Adults · Older Adults
Primary: Change in Balance Score — 5.55; 4.81 seconds — p=0.984
N/A N=265 Physician Radiation Exposure During Radial Access Cardiac Catheterization Using a RAD Board
Radiation Exposure to Operator
Primary: Operator Radiation Exposure — .65; .56 mSv
Phase 4 N=43 Comparison of Combigan Two Times Daily (BID) Versus Simbrinza Three Times Daily (TID)
Glaucoma · Ocular Hypertension
Primary: Intraocular Pressure — 19.7; 18.1; 19.1; 18.8 mmHg
Phase 2 N=38 The Role of Endothelin in Pulmonary Hypertension
Pulmonary Hypertension
Primary: Pulmonary Vascular Resistance (PVR) — 64; 119; 67; 46 dyn*sec/cm^5
Phase 3 N=875 A Study to Compare the Effect of SB3 and Herceptin® in Women With HER2 Positive Breast Cancer
HER2 Positive Early or Locally Advanced Breast Cancer
Primary: The Pathologic Complete Response (pCR) Rate of the Primary Breast Tumour — 42.0; 51.7 percentage of responders
Phase 2 N=77 Fludarabine Phosphate and Total Body Irradiation Followed by a Donor Peripheral Stem Cell Transplant in Treating Patients With Myelodysplastic Syndromes or Myeloproliferative Disorders
Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative · Chronic Myelomonocytic Leukemia · de Novo Myelodysplastic Syndrome
Primary: Number of Patients With HCT Failure. — 4; 0; 0; 5 Participants
Phase 3 N=91 Combination Chemotherapy Followed By Peripheral Stem Cell Transplant in Treating Young Patients With Newly Diagnosed Supratentorial Primitive Neuroectodermal Tumors or High-Risk Medulloblastoma
Anaplastic Medulloblastoma · Medulloblastoma · Supratentorial Embryonal Tumor, Not Otherwise Specified
Primary: Number of Patients Who Have Either a Complete Response (CR) Rate or No Complete Response Rate — 13; 15; 16; 15 Participants — p=0.35
N/A N=49 Smoking Cessation Intervention in Pregnant Women
Smoking Cessation
Primary: Exhaled Carbon Monoxide Levels — 8; 5 Participants
Phase 1 N=180 Trial of MSC1936369B in Subjects With Solid Tumors
Solid Tumors · Cancer
Primary: Number of Subjects Experienced Any Dose-Limiting Toxicity (DLT) Over the First Cycle - Day 1 to 21 — 2; 6; 0; 6 Subjects
Phase 4 N=150 Use of Protamine for Heparin Reversal After Catheter Ablation of Atrial Fibrillation
Atrial Fibrillation · Catheter Ablation
Primary: Time to Ambulation — 480; 316 minutes — p=<0.001
N/A N=92 Efficacy Study of Light Therapy as an Adjunctive Treatment for Parkinson's Disease
Parkinson Disease
Primary: Change in the Combined Scores (Sum) of Parts I, II, and III of the Movement Disorders Society-Unified Parkinson's Disease Rating Scale (M (MDS-UPDRS) From Baseline to…
Phase 2 N=30 Phase II Trial of Revlimid® and Rituximab for Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
Chronic Lymphocytic Leukemia · CLL
Primary: Overall Response Rate (ORR) — 25 Participants
Phase 2 N=271 Efficacy Study of a Cervical Pessary Containing Progesterone for the Prevention of Preterm Delivery
Preterm Birth
Primary: Number of Participants Not Giving Birth Before Week 32 and Week 34 of Gestation — 73; 71; 67; 66 Participants